Picture of Biosig Technologies logo

BSGM Biosig Technologies Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Biosig Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-12.7-17.3-34.5-59.1-32.9
Depreciation
Non-Cash Items5.36.61930.19.71
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.0830.383-0.0722.35-3.45
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-7.47-10.3-15.5-26.6-26.4
Capital Expenditures-0.009-0.308-0.289-0.087-0.542
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0030
Sale of Fixed Assets
Cash from Investing Activities-0.009-0.308-0.286-0.087-0.542
Financing Cash Flow Items5.0110.60
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities7.9713.523.442.810.3
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.4922.97.6616.2-16.6

Or unlock with your email

Or unlock with your email